Genetic Susceptibility to Breast and Ovarian Cancer
Publisher: American College of Medical Genetics 1999
Number of pages: 236
The Guidelines have been prepared to help the primary care provider to participate in the pre- and post-test education and counseling required for every patient contemplating genetic testing for breast and ovarian cancer. Although some important genetic, epidemiological, and clinical issues remain unresolved, it is essential that all health care providers understand the familial basis of some cancers and the potential applications of genetic testing as part of the risk assessment process.
Home page url
Download or read it online for free here:
- American Cancer Society
Breast cancer is a malignant tumor that starts from cells of the breast. A malignant tumor is a group of cancer cells that may grow into surrounding tissues or spread to distant areas of the body. This document refers only to breast cancer in women.
by Alecsandru Ioan Baba, Cornel Catoi - Romanian Academy
Comparative oncology has undergone a special development over the past decades and has attracted the interest of researchers who have studied the etiopathogenesis, morphogenesis and epidemiology, as well as the carcinogens of tumor disease.
- National Academies Press
Genome-Based Diagnostics assesses the evidentiary requirements for clinical utility of molecular diagnostics used to guide treatment decisions for patients with cancer and considers innovative, sustainable research collaborations ...
- Royal College of General Practitioners
The guideline covers twelve groups of cancers: lung, upper gastrointestinal cancers, lower gastrointestinal cancers, breast cancer, gynaecological cancers, urological cancers, haematological cancers, skin cancers, head and neck cancers, etc.